Latest News

Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI

Broomfield, CO – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today their commercial agreement with The Imaging Center in Grand Rapids, MI.  The Imaging Center is a new […]

Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract

Nociscan cost-effectiveness abstract highlights dominance over provocative discography and can save the US healthcare system $283M to $441M annually. The International Society for the Advancement of Spine Surgery (ISASS) Annual Meeting was held June 1-3, 2023. ISASS Policy Statement on Lumbar Spinal Fusion Surgery acknowledges MR Spectroscopy as an effective alternative to provocative discography. Broomfield, CO […]

Aclarion Announces New Engagement with The London Clinic and London Spine Clinic

The London Clinic is the UK’s most renowned independent, private hospital, established 1932. The London Spine Clinic is first specialist spinal unit established in England, 1997. The London Clinic will be Aclarion’s first customer in London.   Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and […]

Aclarion’s Key Opinion Leader Program Adds Ninth Surgeon Advisor with Addition of Dean Karahalios, MD

Development of this program supports Aclarion’s commitment to lead with strong clinical evidence and engage the payer community through key opinion leader advocacy. Aclarion to participate in upcoming ISASS 2023 on  June 1-3, 2023 in San Francisco, CA where their health economics outcomes abstract will presented   Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, […]

Aclarion Appoints Nicholas Theodore, MD as Principal Investigator for CLARITY Post-Market Trial

Nicholas Theodore, MD, FACS, FAANS, is Director of Neurosurgical Spine Center, Johns Hopkins, and Professor of Neurosurgery, Orthopaedics and Biomedical Engineering CLARITY is a post-market, multi-site trial, that will further evaluate the role of Nociscan in the diagnosis and surgical treatment of chronic low back pain. CLARITY is targeted to begin in the second half […]

Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial

  Success rate at 2 years for discogenic low back pain surgeries was 85% for patients whose treatment strategy was consistent with Nociscan-identified discs, a 22 percentage point improvement over patients whose treatment strategy was inconsistent with Nociscan-identified discs (85% vs. 63%; p=0.07) Nociscan is the first augmented intelligence platform to measure pain biomarkers in […]

Request Info or Schedule a Demo

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

8181 Arista Place,
Suite 100
Broomfield, CO 80021

833-ASK-ACON (833-275-2266)